新型临时动脉分流器在军事相关控制性出血猪模型中的性能
本研究为军事相关控制性出血猪模型,雌性猪(70-90 kg)经历30%失血和左髂外动脉阻断30分钟,随机分为Sundt分流器组、TS-VIS动脉压监测组和TS-VIS肝素输注组(10 μ/kg/h),每组5只,用最多3 U全血复苏维持MAP>60 mmHg并监测6小时。TS-VIS两组中位通畅时间均为360分钟,Sundt组为21分钟(p=0.04);Sundt组4例血栓形成(3例在60分钟内),TS-VIS两组各有1例在230-282分钟血栓形成。TS-VIS侧端口肝素输注未显示优于单纯压力监测的获益。
要点
- 在MAP 35.5±7.3 mmHg低血压下置入分流器,TS-VIS两组中位通畅时间360分钟,显著优于Sundt的21分钟(p=0.04)。
- Sundt组5例中4例血栓形成,其中3例发生在60分钟内;TS-VIS两组各1例在230-282分钟血栓形成。
- TS-VIS侧端口肝素输注(10 μ/kg/h)与单纯动脉压监测相比,未观察到额外获益。
- 分流器置入耗时4.5±1.8分钟,组间无差异;通畅期间分流血流维持在对侧的60%-90%。
- 复苏用最多3 U全血维持MAP>60 mmHg,平均26.5±15.5分钟达标。
适用人群与场景
- 军事相关控制性出血猪模型:雌性猪70-90 kg,30%失血+左髂外动脉阻断30分钟。
- 模拟需临时血管分流维持动脉连续性、等待延迟血管重建的军事创伤场景。
诊断标准与关键阈值
- 分流血栓定义:连续无血流超过5分钟。
- 复苏目标:MAP>60 mmHg,使用最多3 U全血。
- 低血压置入:分流置入时MAP 35.5±7.3 mmHg。
处置流程与药物剂量
- 第一步:30%失血并阻断左髂外动脉30分钟。
- 第二步:置入分流器(Sundt、TS-VIS或TS-VIS+肝素),置入耗时4.5±1.8分钟。
- 第三步:用最多3 U全血复苏,维持MAP>60 mmHg,平均26.5±15.5分钟达标。
- 第四步(仅TS-VISHep组):经TS-VIS侧端口输注肝素10 μ/kg/h。
- 第五步:连续监测双侧股动脉血流6小时,无血流>5分钟定义为血栓。
红旗征与不能漏的情况
- Sundt分流器血栓形成率高:5例中4例血栓,3例在60分钟内,需警惕早期分流失败。
- TS-VIS两组血栓发生在230-282分钟,提示仍需监测延迟血栓。
研究设计与关键结果
- 研究类型:军事相关控制性出血猪模型,三组各n=5,单中心动物实验。
- 干预:Sundt分流 vs TS-VIS(动脉压监测) vs TS-VIS+肝素(10 μ/kg/h)。
- 主要终点:中位通畅时间Sundt 21分钟 vs 两个TS-VIS组均360分钟(p=0.04)。
- 血栓事件:Sundt 4/5(3例<60分钟),TS-VIS 1/5(230-282分钟),TS-VISHep 1/5(230-282分钟)。
- 血流:通畅期间所有分流器维持对侧血流的60%-90%;MAP和血流基线及失血后组间无差异。
证据类型、等级与局限
- 证据类型:动物实验(猪模型),样本量小(每组5只),单中心,非随机或随机未明确。
- 局限:动物模型结果不能直接外推至人;样本量小;未报告随机化和盲法细节;肝素剂量为研究方案,非临床推荐。
对床旁实践的改变
- 在低血压和容量限制性复苏条件下,TS-VIS可能提供比Sundt更长的通畅时间,但证据来自猪模型,不能直接改变临床实践。
- TS-VIS侧端口肝素输注未显示额外获益,不支持常规经侧端口局部肝素化。
- 需注意Sundt分流器早期(<60分钟)血栓风险高的动物数据,临床决策仍需结合人类证据。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In military trauma, temporary vascular shunts restore arterial continuity until delayed vascular reconstruction, often for a period of hours. A novel US Air Force-developed trauma-specific vascular injury shunt (TS-VIS) incorporates an accessible side port for intervention or monitoring, which may improve patency under adverse hemodynamic conditions. Our objective was to evaluate TS-VIS patency in the setting of volume-limited resuscitation from hemorrhagic shock.
METHODS: Female swine (70-90 kg) underwent 30% hemorrhage and occlusion of the left external iliac artery for 30 minutes. Animals were allocated to one of three groups (n = 5 per group) by left external iliac artery treatment: Sundt shunt (SUNDT), TS-VIS with arterial pressure monitoring (TS-VIS), or TS-VIS with heparin infusion (10 μ/kg per hour, TS-VISHep). Animals were resuscitated with up to 3 U of whole blood to maintain a mean arterial pressure (MAP) of >60 mm Hg and were monitored for 6 hours. Bilateral femoral arterial flow was continuously monitored with transonic flow probes, and shunt thrombosis was defined as the absence of flow for greater than 5 minutes.
RESULTS: No intergroup differences in MAP or flow were observed at baseline or following hemorrhage. Animals were hypotensive at shunt placement (MAP, 35.5 ± 7.3 mm Hg); resuscitation raised MAP to >60 mm Hg by 26.5 ± 15.5 minutes. Shunt placement required 4.5 ± 1.8 minutes with no difference between groups. Four SUNDT thrombosed (three before 60 minutes). One SUNDT thrombosed at 240 minutes, and two TS-VIS and one TS-VISHep thrombosed between 230 and 282 minutes. Median patency was 21 minutes for SUNDT and 360 minutes for both TS-VIS groups (p = 0.04). While patent, all shunts maintained flow between 60% and 90% of contralateral.
CONCLUSION: The TS-VIS demonstrated sustained patency superior to the Sundt under adverse hemodynamic conditions. No benefit was observed by the addition of localized heparin therapy over arterial pressure monitoring by the TS-VIS side port.
参考来源
- Stigall KS, Sleeter JJ, Thomas SB, et al. Performance of a novel temporary arterial shunt in a military-relevant controlled hemorrhage swine model. J Trauma Acute Care Surg. 2021. PMID: 34117170. doi:10.1097/TA.0000000000003282
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。